Quality statement 6: Investigations

Quality statement

People with lung cancer, following initial assessment and computed tomography (CT) scan, are offered investigations that give the most information about diagnosis and staging with the least risk of harm.

Quality measure

Structure: Evidence of local arrangements and written clinical protocols to ensure that people with lung cancer following initial assessment and CT scan are offered investigations that give the most information about diagnosis and staging with the least risk of harm.

Process:

a) Proportion of people with lung cancer following initial assessment and CT scan who have pathologically confirmed mediastinal staging.

Numerator – the number of people in the denominator who have pathologically confirmed mediastinal staging.

Denominator – the number of people with lung cancer following initial assessment and CT scan.

b) Proportion of people with lung cancer following initial assessment and CT scan who receive 2 or more invasive tests for diagnostic and staging purposes.

Numerator – the number of people in the denominator who receive 2 or more invasive tests for diagnostic and staging purposes.

Denominator – the number of people with lung cancer following initial assessment and CT scan.

Outcome:

a) Complications following invasive or minimally invasive tests.

b) Histological confirmation rate.

c) People with lung cancer who have stage recorded.

What the quality statement means for each audience

Service providers ensure there are systems in place for people with lung cancer following initial assessment and CT scan to be offered investigations that give the most information about diagnosis and staging with the least risk of harm.

Healthcare professionals offer people with lung cancer investigations that give the most information about diagnosis and staging with the least risk of harm, following initial assessment and CT scan.

Commissioners ensure they commission services for people with lung cancer following initial assessment and CT scan to be offered investigations that give the most information about diagnosis and staging with the least risk of harm.

People with lung cancer, after their first assessment and CT scan (a type of scan that uses X‑rays to obtain images of inside the body), are offered further tests that give the most information about the type and stage of their cancer with the least risk of harm.

Source guidance

Lung cancer: diagnosis and management (2019) NICE guideline NG122, recommendations 1.3.1–1.3.28

Data source

Structure: Local data collection.

Process: a) and b) Local data collection.

Outcome:

a) Local data collection.

b) and c) The Health and Social Care Information Centre National Lung Cancer Data Audit collects data on the proportion of patients submitted to the audit who have a histologically confirmed diagnosis of lung cancer with stage recorded.